1st Quarter - Report

THE LIVINGSTON GROUP, LLC for TEVOGEN BIO

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R.____, S.____, FY 2022, Labor/HHS/Education Appropriations bill regarding HHS COVID-19 and virus variant vaccine funding.

LobbyistCovered position, as disclosed
PAUL CAMBON New Fmr. Leg. Dir. Cong. Livingston
BRIAN GLACKIN New Fellow, Sen. Cochran
ROBERT L LIVINGSTON Fmr. Cong. US House
J ALLEN MARTIN Fmr. COS, Cong. Livingston

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.